The expression of PLK-1 in cervical carcinoma: a possible target for enhancing chemosensitivity
Open Access
- 23 September 2009
- journal article
- Published by Springer Nature in Journal of Experimental & Clinical Cancer Research
- Vol. 28 (1) , 130
Abstract
Background: Polo-like kinase-1 (PLK-1) is reported to be upregulated in a variety of human tumors and is implicated in cell proliferation and survival. However, its importance in cervical carcinoma has not yet been fully elucidated. Methods: We examined PLK-1 expression in cervical carcinoma tissues using immunohistochemical staining. Furthermore, we blocked PLK-1 expression in HeLa cells using specific siRNA and detected the cell cycle, cell proliferation and chemosensitivity using western blotting, MTT and flow cytometry. Results: We provide evidence that expression of PLK-1 exists in human cervical carcinoma tissues and establish an association with tumor size. Furthermore, we show that PLK-1 knockdown by transfection of siRNA induces accumulation of HeLa cells in the G2/M cell cycle phase and enhances cisplatin-induced apoptosis. Conclusion: Our results indicate that PLK-1 production in HeLa cells might be critical in determining whether cells survive or undergo apoptosis. Therefore, targeting PLK-1 might be a promising strategy for enhancing sensitivity to chemotherapeutic reagents in cervical carcinoma.Keywords
This publication has 21 references indexed in Scilit:
- Overproduction of Cyclin D1 is dependent on activated mTORC1 signal in nasopharyngeal carcinoma: Implication for therapyCancer Letters, 2009
- Overexpression of transketolase-like gene 1 is associated with cell proliferation in uterine cervix cancerJournal of Experimental & Clinical Cancer Research, 2009
- Polo-like kinase 1 reaches beyond mitosis—cytokinesis, DNA damage response, and developmentCurrent Opinion in Cell Biology, 2008
- Chemotherapy for recurrent cervical cancerCancer Treatment Reviews, 2008
- Overexpression of PLK1 is associated with poor survival by inhibiting apoptosis via enhancement of survivin level in esophageal squamous cell carcinomaInternational Journal of Cancer, 2008
- RNA interference‐mediated silencing of the polo‐like kinase 1 gene enhances chemosensitivity to gemcitabine in pancreatic adenocarcinoma cellsJournal of Cellular and Molecular Medicine, 2008
- Polo-like kinase (Plk)1 depletion induces apoptosis in cancer cellsProceedings of the National Academy of Sciences, 2003
- Polo-like kinases and centrosome regulationOncogene, 2002
- Polo-like kinase (PLK) expression in endometrial carcinomaCancer Letters, 2001
- Expression of polo-like kinase in ovarian cancer is associated with histological grade and clinical stageCancer Letters, 2001